Form 4 for INMB Inmune Bio, Inc.
Accepted 2024-06-26 00:00:00 ET · period of report 2024-06-25 · accession 0001213900-24-055920 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2024-06-26 | 2024-06-25 | INMB | Juda Scott | Dir | P - Purchase | $7.27 | +5,000 | 71.6K | +8% | +$36.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-25 | P | A | 5,000 | $7.27 | 71,603 | I See Footnote | — | — | (F1) The Reporting Person's shares are held by Fossick Capital LP ("Fossick"), a limited partnership. The Reporting Person holds all voting and dispositive control over the Issuer's shares of common stock held by Fossick. |